BCYC · Bicycle Therapeutics PLC · Held by Funds
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of BCYC by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 0.58% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.04% | 25,129 |
| Index ETFs | 0.54% | 379,463 |
| Active ETFs | 0.02% | 12,584 |
| Active funds | 2.24% | 1,560,371 |
| Unclassified | 0.00% | 0 |
| All registered funds | 2.83% | 1,977,547 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding BCYC
24 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | — | 628,421 | $2,664,505 | 0.02% | Long | 2026-06-30 | |
| Small-Mid Cap Equity Fund | TSGUX | 54,440 | $1,110,576 | 0.18% | Long | 2024-11-30 | |
| iShares Biotechnology ETF | IBB | 242,577 | $1,028,526 | 0.01% | Long | 2026-06-30 | |
| Old Westbury Small & Mid Cap Strategies Fund | OWSMX | 265,973 | $1,026,656 | 0.01% | Long | 2026-07-31 | |
| Virtus Biotech Clinical Trials Etf | BBC | 76,743 | $296,228 | 0.64% | Long | 2026-07-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 62,846 | $266,467 | 0.04% | Long | 2026-06-30 | |
| ALPS Medical Breakthroughs ETF | SBIO | 51,450 | $241,301 | 0.15% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | GWX | 30,829 | $130,715 | 0.02% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 25,129 | $117,855 | 0.00% | Long | 2026-05-31 | |
| VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | — | 30,052 | $116,001 | 0.02% | Long | 2026-07-31 | |
| Health Sciences Trust | — | 25,602 | $108,552 | 0.04% | Long | 2026-06-30 | |
| AdvisorShares Alpha DNA Equity Sentiment ETF | — | 5,344 | $107,361 | 0.93% | Long | 2023-09-29 | |
| Range Cancer Therapeutics ETF | CNCR | 6,304 | $69,155 | 0.77% | Long | 2025-02-28 | |
| Invesco NASDAQ Future Gen 200 ETF | QQQS | 13,410 | $62,893 | 0.33% | Long | 2026-05-31 | |
| Horizon Kinetics Medical ETF | MEDX | 12,584 | $53,356 | 0.28% | Long | 2026-06-30 | |
| ActivePassive International Equity ETF | APIE | 11,719 | $48,399 | 0.00% | Long | 2026-08-31 | |
| Steward Values Enhanced International Fund | — | 11,209 | $43,267 | 0.01% | Long | 2026-07-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 9,600 | $40,704 | 0.02% | Long | 2026-06-30 | |
| Harbor International Core Fund | — | 6,102 | $23,554 | 0.00% | Long | 2026-07-31 | |
| TIFF MULTI-ASSET FUND | — | 3,375 | $14,310 | 0.00% | Long | 2026-06-30 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 2,439 | $11,439 | 0.02% | Long | 2026-05-31 | |
| ProShares Ultra Nasdaq Biotechnology | BIB | 1,711 | $8,025 | 0.01% | Long | 2026-05-31 | |
| Harbor Disruptive Innovation ETF | INNO | 276 | $6,471 | 0.18% | Long | 2024-10-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,091 | $4,626 | 0.00% | Long | 2026-06-30 |